(62/ 1 021) с далтепарин: намалението на относителния риск [95% CI] = - 25, 8% [- 49, 7%, 9, 5%].
Selles uuringus oli VTE üldine esinemissagedus 4, 6% (47/ 1027) fondapariinuksi ja 6, 1% (62/ 1021) daltepariini puhul: riskisuhte vähenemine [95% CI] = - 25, 8% [- 49, 7%, 9, 5%].